OVERVIEW
We research and develop biopharmaceutical products based on our patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. In addition, we have gained access to enhancing technologies through licensing and collaborative agreements. We believe the following areas of research offer the greatest potential for our product development efforts:
- Vaccines for use in high-risk populations for infectious disease targets for which there are significant U.S. needs,
- Vaccines for general pediatric or adult populations for infectious disease applications, and
- Cancer vaccines or immunotherapies which complement our existing programs and core expertise.
We plan to continue leveraging our patented technologies through licensing and collaborations. We also plan to use our expertise, infrastructure, and financial strength to explore both in-licensing and acquisition opportunities.